Polenergia S.A. (WSE:PEP)
Poland · Delayed Price · Currency is PLN 60.00
+0.60 (1.01%)
Aug 7, 2025, 5:00 PM CET
Sage Therapeutics Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 4,311 | 4,313 | 5,602 | 7,069 | 3,096 | 1,785 | Upgrade | |
Revenue Growth (YoY) | -18.97% | -23.01% | -20.76% | 128.31% | 73.42% | -28.32% | Upgrade |
Operations & Maintenance | 0.03 | 0.03 | - | 0.14 | - | - | Upgrade |
Selling, General & Admin | 315.27 | 317.64 | 267.54 | 241.43 | 77.81 | 48.97 | Upgrade |
Other Operating Expenses | 3,603 | 3,529 | 4,929 | 6,590 | 2,765 | 1,576 | Upgrade |
Total Operating Expenses | 3,919 | 3,847 | 5,196 | 6,831 | 2,842 | 1,625 | Upgrade |
Operating Income | 392.62 | 465.99 | 405.68 | 237.79 | 253.97 | 160.04 | Upgrade |
Interest Expense | -124.89 | -99.61 | -85.28 | -61.19 | -34.18 | -36.83 | Upgrade |
Interest Income | 44.31 | 43.52 | 44.83 | 36.43 | 0.37 | 2.6 | Upgrade |
Net Interest Expense | -80.58 | -56.09 | -40.45 | -24.76 | -33.81 | -34.23 | Upgrade |
Currency Exchange Gain (Loss) | -21.38 | -3.1 | 1.58 | -3.22 | 1.51 | -1.55 | Upgrade |
Other Non-Operating Income (Expenses) | -7.36 | -11.25 | -32.27 | -9.36 | -7.09 | -3.38 | Upgrade |
EBT Excluding Unusual Items | 275.51 | 395.55 | 334.54 | 200.45 | 214.59 | 120.88 | Upgrade |
Gain (Loss) on Sale of Assets | 0.46 | 0.47 | 0.06 | 0.16 | 225.58 | 0.08 | Upgrade |
Asset Writedown | 0.2 | - | -4.3 | -0.33 | -20.12 | 5.08 | Upgrade |
Legal Settlements | - | - | - | - | - | 0.3 | Upgrade |
Pretax Income | 276.16 | 396.02 | 330.3 | 200.27 | 420.05 | 126.33 | Upgrade |
Income Tax Expense | 72.45 | 94.85 | 66.72 | 40.35 | 85.53 | 17.85 | Upgrade |
Earnings From Continuing Ops. | 203.71 | 301.17 | 263.59 | 159.92 | 334.53 | 108.49 | Upgrade |
Earnings From Discontinued Ops. | - | - | - | - | 2.75 | 2.04 | Upgrade |
Net Income to Company | 203.71 | 301.17 | 263.59 | 159.92 | 337.28 | 110.52 | Upgrade |
Minority Interest in Earnings | - | - | - | - | 0.1 | 0.03 | Upgrade |
Net Income | 203.71 | 301.17 | 263.59 | 159.92 | 337.38 | 110.55 | Upgrade |
Net Income to Common | 203.71 | 301.17 | 263.59 | 159.92 | 337.38 | 110.55 | Upgrade |
Net Income Growth | -28.14% | 14.26% | 64.83% | -52.60% | 205.18% | 1.41% | Upgrade |
Shares Outstanding (Basic) | 77 | 77 | 68 | 61 | 45 | 45 | Upgrade |
Shares Outstanding (Diluted) | 77 | 77 | 68 | 61 | 45 | 45 | Upgrade |
Shares Change (YoY) | 8.69% | 12.89% | 12.22% | 34.12% | - | - | Upgrade |
EPS (Basic) | 2.64 | 3.90 | 3.85 | 2.62 | 7.42 | 2.43 | Upgrade |
EPS (Diluted) | 2.64 | 3.90 | 3.85 | 2.62 | 7.42 | 2.43 | Upgrade |
EPS Growth | -33.80% | 1.30% | 46.95% | -64.69% | 205.35% | 1.30% | Upgrade |
Free Cash Flow | 395.52 | 518.47 | 294.74 | -414.07 | -432.17 | -127.86 | Upgrade |
Free Cash Flow Per Share | 5.12 | 6.71 | 4.31 | -6.79 | -9.51 | -2.81 | Upgrade |
Profit Margin | 4.72% | 6.98% | 4.71% | 2.26% | 10.90% | 6.19% | Upgrade |
Free Cash Flow Margin | 9.17% | 12.02% | 5.26% | -5.86% | -13.96% | -7.16% | Upgrade |
EBITDA | 544.37 | 618.1 | 545.89 | 339.82 | 338.71 | 250.78 | Upgrade |
EBITDA Margin | 12.63% | 14.33% | 9.74% | 4.81% | 10.94% | 14.05% | Upgrade |
D&A For EBITDA | 151.75 | 152.12 | 140.21 | 102.03 | 84.74 | 90.74 | Upgrade |
EBIT | 392.62 | 465.99 | 405.68 | 237.79 | 253.97 | 160.04 | Upgrade |
EBIT Margin | 9.11% | 10.80% | 7.24% | 3.36% | 8.20% | 8.96% | Upgrade |
Effective Tax Rate | 26.24% | 23.95% | 20.20% | 20.15% | 20.36% | 14.13% | Upgrade |
Revenue as Reported | 4,317 | 4,321 | 5,615 | 7,089 | 3,999 | 1,811 | Upgrade |
Source: S&P Global Market Intelligence. Utility template. Financial Sources.